mobile nav toggler

events and webcasts

Provention Bio Reports Top Line Results from Phase 2a PRINCE Clinical Trial with PRV-6527, an Oral CSF-1R Inhibitor, in Patients with Moderate to Severe Crohn's Disease
 Tuesday, October 22, 2019
 8:30am EDT